A Proof-Of-Principle Study of Epigenetic Therapy Added to Neoadjuvant Doxorubicin Cyclophosphamide for Locally Advanced Breast Cancer-Reference-Cited by-同舟云学术

A Proof-Of-Principle Study of Epigenetic Therapy Added to Neoadjuvant Doxorubicin Cyclophosphamide for Locally Advanced Breast Cancer

Published:2006-12-20 Issue:1 Volume:1 Page:e98
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Arce Claudia,Pérez-Plasencia Carlos,González-Fierro Aurora,de la Cruz-Hernández Erick,Revilla-Vázquez Alma,Chávez-Blanco Alma,Trejo-Becerril Catalina,Pérez-Cárdenas Enrique,Taja-Chayeb Lucia,Bargallo Enrique,Villarreal Patricia,Ramírez Teresa,Vela Teresa,Candelaria Myrna,Camargo Maria F.,Robles Elizabeth,Dueñas-González Alfonso

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference71 articles.

1. The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells.;WG Zhu;Curr Med Chem Anti-Cancer Agents,2003

2. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.;EE Cameron;Nat Genet,1999

3. Epigenetic hypothesis tests for methylation and acetylation in a triple microarray system.;L Li;J Comput Biol,2005

4. Synergistic antineoplastic action of DNA methylation inhibitor 5-AZA-2′-deoxycytidine and histone deacetylase inhibitor depsipeptide on human breast carcinoma cells.;M Primeau;Int J Cancer,2003

5. DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors.;WG Zhu;Cancer Res,2001

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the epigenome with advanced delivery strategies for epigenetic modulators;Bioengineering & Translational Medicine;2024-08-17

2. Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies;Biomedicine & Pharmacotherapy;2024-05

3. Research progress and applications of epigenetic biomarkers in cancer;Frontiers in Pharmacology;2024-04-12

4. Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line;PLOS ONE;2023-09-28

5. Clinical Applications of Histone Deacetylase Inhibitors;Handbook of Epigenetics;2023